EQUELS THOMAS K (Exec. Vice Chairman/CEO/Pres.) purchased 31.5% of their position (22K shares) of AIM IMMUNOTECH INC. on the open market
Open‑market purchase worth $4.9K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/16/2026ACC: 0001493152-26-042848
DirectorOfficer· Exec. Vice Chairman/CEO/Pres.
Since Jul 2018
+22K
Net shares
Net buyer
$4.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
22K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22K
Price / share
$0.22
Trade value
$4.86K
% of position
31.5%
9/15/2026
69.82K→91.82K
Total
Net shares
+22K
Net value
$4.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | P · Purchase | +22K | $0.22 | $4.86K | 31.5% | 69.82K | 91.82K |
| Total | +22K | $4.86K | ||||||
Derivative Transactions0
No derivative transactions reported